Scholars Central

Conference abstract

In vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands

Authors: Marta Truffi, Luisa Fiandra, Serena Mazzucchelli, Miriam Colombo, Raffaele Allevi, Davide Prosperi, Fabio Corsi

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The identification of new strategies aimed to optimize the detection and treatment of primary breast cancer and metastases represents a great technical and medical challenge. Target-specific nanodevices may allow to combine specific tumor recognition with the capability to act as a drug reservoir for the selective delivery of chemotherapics to tumor sites. At present, the importance of surface functionalization of nanoparticles to improve their in vivo localization at the tumor is still controversial. Here, we have designed and developed a set of multifunctional nanoprobes, modified with three different variants of the model antibody trastuzumab (TZ), a widely used therapeutic agent for the management of HER2-positive breast cancer. We have performed a comparative study of internalization, trafficking, and metabolism in breast tumor cells of multifunctional nanoparticles (MNP) functionalized with either the entire TZ or alternative lower molecular weight variants of the monoclonal antibody, such as the half-chain (HC) and a single chain variable fragment (scFv). Then, we have estimated to what extent the structure of the surface bioligand could affect the targeting efficiency of the nanoconjugate in both in vitro and in vivo settings, and found that the highly stable MNP-HC is the best candidate for application in breast cancer detection. Our results provide evidence that a specific functionalization of nanoconstructs may afford long-term action in cancer cells in vivo. Furthermore, the longer period of accumulation of MNP-HC in the tumor makes this nanoparticle a promising candidate for future application in breast cancer diagnosis and treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutica Analytica Acta.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutica Analytica Acta
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Marta Truffi”
  • BylineArticles whose byline prints “Luisa Fiandra”
  • BylineArticles whose byline prints “Serena Mazzucchelli”
  • BylineArticles whose byline prints “Miriam Colombo”
  • BylineArticles whose byline prints “Raffaele Allevi”
  • BylineArticles whose byline prints “Davide Prosperi”
  • BylineArticles whose byline prints “Fabio Corsi”